AU2114899A - Nucleotide expression systems with reduced immunogenicity for use in gene therapy - Google Patents

Nucleotide expression systems with reduced immunogenicity for use in gene therapy

Info

Publication number
AU2114899A
AU2114899A AU21148/99A AU2114899A AU2114899A AU 2114899 A AU2114899 A AU 2114899A AU 21148/99 A AU21148/99 A AU 21148/99A AU 2114899 A AU2114899 A AU 2114899A AU 2114899 A AU2114899 A AU 2114899A
Authority
AU
Australia
Prior art keywords
gene therapy
expression systems
reduced immunogenicity
nucleotide expression
nucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21148/99A
Other languages
English (en)
Inventor
Charles J. Link Jr.
Thomas J. Radosevich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Gene Therapy Research Institute
Original Assignee
Human Gene Therapy Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Gene Therapy Research Institute filed Critical Human Gene Therapy Research Institute
Publication of AU2114899A publication Critical patent/AU2114899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU21148/99A 1998-01-14 1999-01-13 Nucleotide expression systems with reduced immunogenicity for use in gene therapy Abandoned AU2114899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7140998P 1998-01-14 1998-01-14
US60071409 1998-01-14
PCT/US1999/000733 WO1999036562A1 (en) 1998-01-14 1999-01-13 Nucleotide expression systems with reduced immunogenicity for use in gene therapy

Publications (1)

Publication Number Publication Date
AU2114899A true AU2114899A (en) 1999-08-02

Family

ID=22101129

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21148/99A Abandoned AU2114899A (en) 1998-01-14 1999-01-13 Nucleotide expression systems with reduced immunogenicity for use in gene therapy

Country Status (5)

Country Link
EP (1) EP1045920A1 (ja)
JP (1) JP2002508976A (ja)
AU (1) AU2114899A (ja)
CA (1) CA2318664A1 (ja)
WO (1) WO1999036562A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001095725A1 (en) * 2000-06-13 2001-12-20 The Executive Director Of The Department Of Conservation And Land Management Biological control of pest animals

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019195B4 (de) * 2000-04-17 2006-03-09 Heart Biosystems Gmbh Reversible Immortalisierung
AU2001288682A1 (en) 2000-08-30 2002-03-13 Chemocentryx, Inc. Inhibition of cmv infection and dissemination
WO2002062296A2 (en) 2001-02-02 2002-08-15 Chemocentryx, Inc. Methods and compositions useful for stimulating an immune response
EP3768307A1 (en) * 2018-03-19 2021-01-27 Boehringer Ingelheim Vetmedica GmbH New ehv with inactivated ul18 and/or ul8

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750398A (en) * 1993-11-30 1998-05-12 David C. Johnson Vector, element and method for inhibiting immune recognition
US5846806A (en) * 1994-07-29 1998-12-08 American Cyanamid Company Identification of a human cytomegalovirus gene region involved in down-regulation of MHC class I heavy chain expression
WO1996031241A1 (en) * 1995-04-04 1996-10-10 Cell Genesys, Inc. Transplantation of genetically modified cells having low levels of class i mhc proteins on the cell surface
US5891857A (en) * 1996-02-20 1999-04-06 Vanderbilt University Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001095725A1 (en) * 2000-06-13 2001-12-20 The Executive Director Of The Department Of Conservation And Land Management Biological control of pest animals

Also Published As

Publication number Publication date
JP2002508976A (ja) 2002-03-26
WO1999036562A1 (en) 1999-07-22
WO1999036562A9 (en) 1999-09-30
EP1045920A1 (en) 2000-10-25
CA2318664A1 (en) 1999-07-22

Similar Documents

Publication Publication Date Title
AU1606897A (en) Thymidine kinase variants, corresponding nucleic acid sequences and their use in gene therapy
AU2946295A (en) Targeted gene delivery system
AU3369900A (en) Gene silencing
AU3719700A (en) Enzymatic dna molecules that contain modified nucleotides
AU3739697A (en) Gene delivery system
AU3316600A (en) Gene expression in bladder tumors
AU1201600A (en) Controlling gene expression in living cells
AU4065997A (en) Non-viral vehicles for use in gene transfer
HUP0102800A2 (hu) A fitáz gének túlexpresszálása élesztőrendszerekben
AU2637100A (en) Delivery system and methods for gene therapy
AU1099701A (en) Alpha1-3 galactosyltransferase gene and promoter
AUPQ262599A0 (en) Gene expression
AU1927699A (en) Nucleotide polymorphisms in soybean
AU7119400A (en) Single nucleotide polymorphisms in genes
AU4425397A (en) Antisense gene therapy for rna viruses
AU2114899A (en) Nucleotide expression systems with reduced immunogenicity for use in gene therapy
AU5178999A (en) Nucleic acid delivery
AU6254799A (en) Anti-ige gene therapy
AU2732000A (en) Reverse gene therapy
AU2153401A (en) Gene expression in biological conditions
AU3457899A (en) Blk genes, gene products and uses thereof in apoptosis
AU1541399A (en) Human nucleotide pyrophosphohydrolase-2
AU6578798A (en) Sugar-regulatory sequences in alpha-amylase genes
AU4328399A (en) Nucleic acid-cobalamin complexes and their use in gene therapy
GB9924981D0 (en) Gene therapy

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase